Product NDC: | 0115-2790 |
Proprietary Name: | Chloroquine Phosphate |
Non Proprietary Name: | CHLOROQUINE PHOSPHATE |
Active Ingredient(s): | 250 mg/1 & nbsp; CHLOROQUINE PHOSPHATE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0115-2790 |
Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA080880 |
Marketing Category: | ANDA |
Start Marketing Date: | 19741211 |
Package NDC: | 0115-2790-02 |
Package Description: | 500 TABLET in 1 BOTTLE (0115-2790-02) |
NDC Code | 0115-2790-02 |
Proprietary Name | Chloroquine Phosphate |
Package Description | 500 TABLET in 1 BOTTLE (0115-2790-02) |
Product NDC | 0115-2790 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CHLOROQUINE PHOSPHATE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19741211 |
Marketing Category Name | ANDA |
Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories, Inc. |
Substance Name | CHLOROQUINE PHOSPHATE |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antimalarial [EPC] |